These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3773196)

  • 21. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both?
    Perkins RB; Stier EA
    Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666
    [No Abstract]   [Full Text] [Related]  

  • 22. The Papanicolaou smear. Medicine's most successful cancer screening procedure is threatened.
    Austin RM; McLendon WW
    JAMA; 1997 Mar; 277(9):754-5. PubMed ID: 9042850
    [No Abstract]   [Full Text] [Related]  

  • 23. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and use of papanicolaou test among HIV-positive women.
    Serraino D; Pavia C; Navarra A; Piselli P; Pisani G; Scuderi M; Secchia SB; Capobianchi M; Ippolito G;
    Int J Cancer; 2005 Jul; 115(6):1009-10. PubMed ID: 15751031
    [No Abstract]   [Full Text] [Related]  

  • 25. Confusion about Pap smears: lack of knowledge among high-risk women.
    Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
    J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Leidy NK; Brown R; Luce B; Sheets E
    JAMA; 1999 Oct; 282(15):1419; author reply 1420. PubMed ID: 10535423
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
    Sedlacek TV
    JAMA; 1999 Oct; 282(15):1419-20. PubMed ID: 10535424
    [No Abstract]   [Full Text] [Related]  

  • 28. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 29. Pap smears in perspective.
    S Afr Med J; 1983 Dec; 64(25):967-8. PubMed ID: 6648734
    [No Abstract]   [Full Text] [Related]  

  • 30. Testing for human papillomavirus in women with abnormal pap smear results.
    McCaffery KJ; Waller J; Forrest S; Wardle J
    JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
    [No Abstract]   [Full Text] [Related]  

  • 31. The Papanicolaou test and screening for cervical cancer.
    Vasilev SA; Scott RS
    JAMA; 1997 Aug; 278(8):634. PubMed ID: 9272890
    [No Abstract]   [Full Text] [Related]  

  • 32. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal Pap smears, ASCUS still ob/gyn puzzle.
    Titus K
    JAMA; 1996 Oct; 276(13):1014-6. PubMed ID: 8847749
    [No Abstract]   [Full Text] [Related]  

  • 34. The cost-effectiveness of cervical cancer screening for low-income elderly women.
    Mandelblatt JS; Fahs MC
    JAMA; 1988 Apr 22-29; 259(16):2409-13. PubMed ID: 3127608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papanicolaou cervical smears for screening in asymptomatic women.
    Barnes BA
    Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General practice characteristics and use of Pap-smear.
    Hansen D; Ejlersen E; Olesen F
    Scand J Prim Health Care; 1991 Sep; 9(3):224. PubMed ID: 1754757
    [No Abstract]   [Full Text] [Related]  

  • 37. The significance of a negative Papanicolaou smear with hyperkeratosis or parakeratosis.
    Andrews S; Miyazawa K
    Obstet Gynecol; 1989 May; 73(5 Pt 1):751-3. PubMed ID: 2704502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
    Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
    Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papanicolaou testing.
    JAMA; 1985 Jun; 253(22):3250-2. PubMed ID: 3999310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.